CI
RGEN icon

Cigna Investments’s Repligen RGEN Stock Holding History

Cigna Investments’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,207
Closed -$319K – 640
2021
Q4 		$319K Sell
1,207
-440
-27% -$119K 0.02% 490
2021
Q3 		$477K Hold
1,647
– – 0.04% 434
2021
Q2 		$329K Sell
1,647
-193
-10% -$37.4K 0.02% 540
2021
Q1 		$358K Buy
1,840
+113
+7% +$23.2K 0.02% 543
2020
Q4 		$331K Buy
1,727
+171
+11% +$31.1K 0.03% 522
2020
Q3 		$230K Buy
+1,556
New +$222K 0.02% 558

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cigna Investments's RGEN Position: Q1 2022 in Review

Cigna Investments sold out of Repligen (RGEN) in Q1 2022, closing a stake of 1,207 shares — an estimated $319K sold.

Cigna Investments first reported a position in RGEN in Q3 2020 and held it in 6 quarters. The position peaked at $477K in Q3 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Cigna Investments reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Cigna Investments sold 1,207 Repligen shares in Q1 2022, an estimated $319K.
  • Cigna Investments first reported a position in Repligen in Q3 2020 and held it in 6 quarters.
  • Cigna Investments's Repligen position peaked at $477K in Q3 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Cigna Investments's 13F filing for Q1 2022, filed 13 May 2022.